GamaSTAN Immune Globulin (Human) Treatment Single-Dose Vial * Refrigerated (RX)

Proven Passive Immunity for Hepatitis A, Measles, Rubella, and Varicella Exposure

Trusted Protection, Fast Immunity—FDA-Approved Human Immune Globulin for Post-Exposure Prophylaxis

When rapid, targeted immunological support is essential, medical professionals turn to GamaSTAN Immune Globulin (Human) Treatment by Grifols Therapeutics. Developed to deliver immediate, passive antibody protection, GamaSTAN is the gold standard for post-exposure prophylaxis against Hepatitis A, Measles (Rubeola), Rubella, and Varicella (chickenpox). Available in a convenient, premeasured single-dose vial, this injectable solution is carefully purified from human plasma and manufactured to the highest safety and efficacy standards.

Clinical Applications:

GamaSTAN Immune Globulin is a trusted, FDA-approved solution for healthcare professionals seeking to provide:

• Post-Exposure Prophylaxis (PEP):
  • Hepatitis A: For susceptible individuals exposed to Hepatitis A virus (HAV)
  • Measles: For non-immune individuals exposed to confirmed measles (rubeola) cases
  • Varicella (Chickenpox): For high-risk individuals exposed to varicella-zoster virus
  • Rubella: For immediate passive protection where rubella risk is high and vaccination is contraindicated
• Temporary Immune Support for immunocompromised patients unable to mount an adequate vaccine response
• Protection for International Travelers: Guarding against prevalent infectious diseases in high-risk areas

GamaSTAN delivers human immune globulin with a proven efficacy and safety profile. As a plasma-derived medication, it supplies IgG antibodies to bridge the gap until the recipient’s immune system can respond or until vaccination becomes effective.

Features & Benefits

• Immediate Passive Immunity: Provides rapid-acting immunoglobulin (IgG) antibodies for immediate post-exposure protection.
• FDA-Approved for Multiple Indications: Indicated for prophylaxis and protection following exposure to Hepatitis A virus, Measles, Rubella, and Varicella.
• Single-Dose, Ready-to-Use Vial: Ensures precise dosing, reduces waste, and supports safe administration in hospital, clinic, or travel medicine settings.
• Purified Human Immune Globulin: Manufactured from carefully screened donors, virus-inactivation and removal processes ensure product safety.
• Trusted by Physicians and Hospitals: Backed by Grifols Therapeutics—a global leader in immunotherapy and plasma protein therapeutics.

Directions for Use

• Administration: For intramuscular injection only. Dosage depends on indication, patient body weight, and risk assessment. Refer to the prescribing information for detailed dosing guidelines.
• For optimal protection, administer as soon as possible after exposure.
• Professional Use Only: For use by or under the supervision of a healthcare professional.

Why Choose GamaSTAN Immune Globulin by Grifols?

• FDA-approved for multiple, life-threatening viral exposures
• Fast-acting solution for urgent healthcare and public health needs
• Manufactured using advanced purification and viral inactivation processes
• Precise single-dose vials for reliable, controlled administration
• Widely used and trusted in hospitals, clinics, and travel medicine practices

Important Safety Information

• Contraindications: Do not use in individuals with known severe allergic reactions to human immunoglobulins.
• Cautions: Use with care in patients with IgA deficiency or a history of anaphylaxis to immunoglobulins.
• Side Effects: Rarely, may include injection site reactions, headache, fever, or allergic reactions.
• Monitor patients as per clinical guidelines when administering any biologic product.

Order Information

• Presentation: Single-dose vial for intramuscular injection
• Manufacturer: Grifols Therapeutics

Protect your patients and community with the gold standard in passive immunity—GamaSTAN Immune Globulin (Human) Treatment by Grifols Therapeutics. Ensure immediate antibody protection for Hepatitis A, Measles, Varicella, and Rubella today.